Search hospitals > Washington > Seattle
Harborview Medical Center
Claim this profileSeattle, Washington 98104
Global Leader in Delayed Wound Healing
Global Leader in Lymphoma
Conducts research for Lung Cancer
Conducts research for Stroke
Conducts research for Breast Cancer
419 reported clinical trials
24 medical researchers
Summary
Harborview Medical Center is a medical facility located in Seattle, Washington. This center is recognized for care of Delayed Wound Healing, Lymphoma, Lung Cancer, Stroke, Breast Cancer and other specialties. Harborview Medical Center is involved with conducting 419 clinical trials across 560 conditions. There are 24 research doctors associated with this hospital, such as Charles Landis, MD, Charles Bernick, Michael Levitt, MD, and Lakshmi Rajdev.Area of expertise
1Delayed Wound Healing
Global Leader2Lymphoma
Global LeaderStage II
Stage IV
Stage III
Top PIs
Charles Landis, MDUniversity of Washington (UW) - Harborview Medical Center (HMC) - Hepatitis and Liver Clinic4 years of reported clinical research
Studies Fatty Liver
Studies Non-alcoholic Fatty Liver Disease
5 reported clinical trials
6 drugs studied
Charles BernickMemory and Brain Wellness Center at Harborview1 year of reported clinical research
Studies Alzheimer's Disease
Studies Problem Behavior
5 reported clinical trials
7 drugs studied
Michael Levitt, MDHarborview Medical Center3 years of reported clinical research
Studies Stroke
Studies Subdural Hematoma
4 reported clinical trials
6 drugs studied
Lakshmi RajdevSiteman Cancer Center at Washington University9 years of reported clinical research
Studies Anal Cancer
Studies Skin Cancer
3 reported clinical trials
4 drugs studied
Clinical Trials running at Harborview Medical Center
Stroke
Lymphoma
Traumatic Brain Injury
Delayed Wound Healing
Sleep Apnea
Obstructive Sleep Apnea
Depression
Chronic Disease
Cancer
Subcortical Brain Damage
Anti-Coagulant + Anti-Platelet Therapy
for Stroke Prevention
The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic stroke, intracerebral hemorrhage, or vascular death.
Recruiting2 awards Phase 36 criteria
Fluoxetine
for Poststroke Depression
A double-blinded placebo-controlled randomized trial to evaluate the effect of preventative treatment of depression in survivors of aneurysmal subarachnoid hemorrhage (aSAH), a type of stroke.
Recruiting2 awards Phase 23 criteria
Semaglutide
for Type 2 Diabetes
A human subjects research study, the primary purpose of which is to assess the EFFECTS OF SEMAGLUTIDE ON INTRACRANIAL BLOOD FLOW AND BLOOD-BRAIN BARRIER PERMEABILITY IN TYPE-2 DIABETES (T2D) through testing of the intervention on patients in a clinical setting. The study will randomize subjects with diabetes to either semaglutide or matching placebo. Magnetic resonance images will be primary endpoint measured at baseline and at one year to assess effect of this FDA approved medication. Given the available evidence supporting the neuroprotective effect of this drug class and stroke reduction with semaglutide, and the investigators preliminary data showing that T2D had significantly reduced total number of distal arterial branches in the brain than non-T2D, the investigators expect treatment with semaglutide will be associated with improved intracranial blood flow condition.
Recruiting2 awards Phase 45 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Harborview Medical Center?
Harborview Medical Center is a medical facility located in Seattle, Washington. This center is recognized for care of Delayed Wound Healing, Lymphoma, Lung Cancer, Stroke, Breast Cancer and other specialties. Harborview Medical Center is involved with conducting 419 clinical trials across 560 conditions. There are 24 research doctors associated with this hospital, such as Charles Landis, MD, Charles Bernick, Michael Levitt, MD, and Lakshmi Rajdev.
Where is Harborview Medical Center located?
Harborview Medical Center is situated at 325 Ninth Avenue, Seattle, Washington, nestled between Jefferson and Alder streets on First Hill. For those driving, access is straightforward from Interstate 5: exit at James Street, then head east and turn right onto Ninth Avenue, proceeding one block to Jefferson Street. Public transportation is readily available via King County Metro Transit, with routes No. 3, No. 4, and No. 60 serving Harborview.
Who should I call to ask about financial aid or insurance network?
**Harborview Medical Center Financial Assistance:**
- For financial assistance, contact 206.744.3084 or visit [www.valleymed.org](http://www.valleymed.org). Assistance is available for eligible patients, with discounts based on gross family income.
**Insurance Inquiries:**
- Contact Patient Financial Services at 206-520-0400 or 855-520-0400. More information is available on the UW Medicine website under Patient Billing & Insurance.
**Medical Records:**
- For medical records, reach out to Enterprise Record and Health Information at 206-744-9000 or email uwmedroi@uw.edu.
**Concerns or Complaints:**
- Contact Patient Relations at 206-598-8382 or email UWMCares@uw.edu for any concerns or complaints.
What insurance does Harborview Medical Center accept?
Harborview Medical Center accepts a wide range of insurance plans, including but not limited to Aetna, Cigna, First Choice Health, and UnitedHealthcare. Coverage types such as HMO, PPO, and EPO are available, but may vary by plan. Always verify your plan and network coverage directly with the hospital or insurance provider to confirm service coverage.
What awards or recognition has Harborview Medical Center received?
Harborview Medical Center, in partnership with the University of Washington School of Medicine, secures over $240 million annually for research and training. It is renowned for its contributions to biological and clinical sciences research, including translational and basic research, clinical studies, treatment trials, epidemiology, and health services research. The center boasts facilities and resources that foster interdisciplinary collaborations, translating biomedical knowledge into advanced treatments and medical innovations.